Test Story

By: NewsUSA

March 27, 2025 at 20:00 PM EDT

(NewsUSA) - For more details, including important safety information, on VenaSeal, visit: https://www.medtronic.com/breakfree.

Sources

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi: 10.1016/j.jvs.2011.01.079.

Mayo Clinic: Varicose Veinshttps://www.mayoclinic.org/diseases-conditions/varicose-veins/symptoms-causes/syc-20350643

National Heart Lung and Blood Institute: Varicose Veins https://www.nhlbi.nih.gov/health/varicose-veins

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994. doi: 10.1016/j.jvs.2014.11.071.

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. doi: 10.1016/j.jvsv.2020.05.019.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658–666. doi: 10.1016/j.jvsv.2017.03.016.

Symbol	Price	Change (%)
AMZN	213.77	+0.98 (0.46%)
AAPL	253.50	-5.36 (-2.07%)
AMD	221.53	+1.35 (0.61%)
BAC	50.28	+0.22 (0.44%)
GOOG	303.93	+6.27 (2.11%)
META	575.05	+2.03 (0.35%)
MSFT	372.29	-0.59 (-0.16%)
NVDA	178.10	+0.46 (0.26%)
ORCL	143.17	-2.37 (-1.63%)
TSLA	346.65	-6.17 (-1.75%)

Symbol

Price

Change (%)

AMZN

213.77

+0.98 (0.46%)

AAPL

253.50

-5.36 (-2.07%)

AMD

221.53

+1.35 (0.61%)

BAC

50.28

+0.22 (0.44%)

GOOG

303.93

+6.27 (2.11%)

Test Story

More News

Recent Quotes

Starting at $3.75/week.

Subscribe Today